Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Anthony Kahr (NPI 1558686352)

Field	Value
Entity Type	Individual
Organization	Anthony Kahr
Address	1501 Ne Medical Center Dr
City	Bend
State	OR
ZIP	97701
Taxonomy	Rheumatology Physician
NPI Enumerated	April 5, 2010

Payer Source	Total Paid
Medicare	$2.8M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-focused practice: lifetime Medicare revenue is $2.8M and there is no Medicaid billing on file, so payer mix is single-payer heavy for public programs. The NPI was enumerated on 2010-04-05 (≈16 years ago), indicating a well-established billing history in Medicare.

Revenue is highly concentrated in a small set of injectable therapies: the top 3 Medicare codes account for 51.8% of total Medicare revenue, with J2350 alone representing $825.6K (29.4% of Medicare revenue). This level of concentration means a large share of the provider’s Medicare income is tied to a few specialty drug administrations.

The code mix indicates an infusion- and drug-administration business model rather than a visit-centered practice: high-revenue items are biologic and bone-targeted injectables such as J2350 (19.2K claims), J0129 (9.9K claims), and J0897 (17.4K claims). Lower contribution from E/M codes (for example 99214 accounts for $57.5K, 2.0% of Medicare revenue) reinforces that drug administration and infusion services are the primary service line.

Competitive standing is mixed across specific therapies: the provider is notably above typical national volume for J0897 (ranks #388 of 10057, 96th percentile) and is an extreme outlier for J3489 (ranks #3 of 3032, 100th percentile), indicating strong relative activity in those products. By contrast, J2350 ranks #28 of 105 (73rd percentile) and J0129 ranks #490 of 1221 (60th percentile), which are described as typical or unremarkable volumes at the national level.

Infusion and chemotherapy administration codes show unusually high throughput relative to peers: 96365 ranks in the 97th percentile and 96415 in the 98th percentile, while 96372 is also in the 98th percentile, suggesting a busy infusion suite and frequent short-duration administrations. These high percentiles for administration/add-on codes complement the high volumes of drug-specific J-codes and point to operational capacity for repeated infusions.

The provider bills both originator biologics and biosimilars across multiple agents, indicating a diverse biologics formulary: examples include J1745 (infliximab originator, $161.7K) alongside Q5103 (infliximab-dyyb biosimilar, $34.7K) and Q5119 (rituximab-pvvr biosimilar, $46K). This mix suggests either switching or simultaneous use of branded and biosimilar products within the practice’s infusion mix.

Clinical breadth spans immunomodulatory and bone health therapies: high-revenue agents include immunology biologics such as J0129 (abatacept, $316K) and J3262 (tocilizumab, $249.6K) alongside bone-targeted therapies like J0897 (denosumab, $313.2K) and J3111 (romosozumab, $184.8K). The combination of these agents is consistent with a rheumatology-focused practice that also manages osteoporosis and related bone conditions.

Operational data show very high claim counts on some low-paid-per-unit codes (for example J3262 has 49.9K claims at $5 avg paid/claim totaling $249.6K), which implies many small billing units or frequent repeat administrations driving volume. Monitoring unit economics and infusion workflow efficiency would be important for understanding margins given the disparity between high claim counts and modest average payment amounts.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

50 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2350	Injection, ocrelizumab, 1 mg	19,200	$40	$825.6K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	9,880	$30	$316K
J0897	Injection, denosumab, 1 mg	17,400	$20	$313.2K
J3380	Injection, vedolizumab, intravenous, 1 mg	18,000	$20	$306K
J3262	Injection, tocilizumab, 1 mg	49,920	$10	$249.6K
J3111	Injection, romosozumab-aqqg, 1 mg	23,100	$10	$184.8K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6,220	$30	$161.7K
J9312	Injection, rituximab, 10 mg	1,750	$60	$99.8K
J1602	Injection, golimumab, 1 mg, for intravenous use	8,200	$10	$90.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	680	$90	$57.5K

Showing 1–10 of 50

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 50 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

Anthony Kahr — 10 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

50 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	1	10	14,100	$40	$605.4K
J0129	5	20	6,300	$30	$260.7K
J9312	7	10	3,750	$60	$220K
J3262	3	10	31,180	$1	$176.4K
J1602	16	20	13,600	$10	$156.4K
J3380	1	10	4,800	$20	$134.3K
J1745	6	20	3,750	$30	$115.2K
J3111	1	10	12,710	$10	$107K
J0897	1	70	2,400	$20	$78.3K
Q5119	2	10	1,970	$20	$66.1K

Showing 1–10 of 50

Related Providers

Other providers that share a Tax Identification Number (TIN) with Anthony Kahr, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bend Memorial Clinic PC	OR	Family Medicine Physician	$0	$11.7M
Klamath Tribal Health & Family Services	OR	Federally Qualified Health Center (FQHC)	$0	$8.6M
Laith Kadasi	OR	Ophthalmology Physician	$2.2M	$0
Gregory Borstad	NC	Rheumatology Physician	$1.6M	$0
Christina Bright	OR	Rheumatology Physician	$1.4M	$0
William Schmidt	OR	Hematology & Oncology Physician	$1.4M	$0
Benjamin Miriovsky	AL	Hematology & Oncology Physician	$1.3M	$0
Adam Williams	OR	Allergy & Immunology Physician	$1.3M	$0
David Greenberg	OR	Diagnostic Radiology Physician	$997.3K	$0
Heather Hansen-dispenza	OR	Rheumatology Physician	$726.8K	$0

Nearby Providers

Other providers in the same ZIP code as Anthony Kahr, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ortc, LLC	OR	Substance Abuse Rehabilitation Facility	$747.3K	$16.2M
Telecare Mental Heatlh Service Of Oregon, Inc	OR	Mental Illness Community Based Residential Treatment Facility	$0	$12.8M
Pfeifer & Associates	OR	Community/Behavioral Health Agency	$0	$11.6M
Grants Pass Treatment Center	OR	Substance Abuse Rehabilitation Facility	$0	$9.5M
St. Charles Health System, Inc.	OR	Family Medicine Physician	$0	$8.6M
Deschutes County Oregon	OR	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$7.9M
Central Oregon Pediatric Associates	OR	Pediatrics Physician	$0	$7.2M
Bend Surgery Center LLC	OR	Ambulatory Surgical Clinic/Center	$4.8M	$1.7M
Adam Angeles	OR	Plastic and Reconstructive Surgery Physician	$6.5M	$0
Central Oregon Emergency Physicians LLC	OR	Emergency Medical Services (Emergency Medicine) Physician	$0	$5.2M

Anthony Kahr — Billing Profile & Reimbursement Data

Sign up for Anthony Kahr — Billing Profile & Reimbursement Data policy alerts

Anthony Kahr — Billing Profile & Reimbursement Data

Sign up for Anthony Kahr — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References